Read + Share
. Erratum to "Cabozantinib for previously treated radioiodine-refractory
differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311
trial". Cancer 2023 Jan 13. doi: 10.1002/cncr.34638.
PMID: 36637398
|
 |
|
. Erratum to "Cabozantinib for previously treated radioiodine-refractory
differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311
trial". Cancer 2023 Jan 13. doi: 10.1002/cncr.34638.
PMID: 36637398
|
|
|
|